デフォルト表紙
市場調査レポート
商品コード
1482446

遺伝子毒性検査市場:製品タイプ、エンドユーザー、地域別:世界の産業分析、規模、シェア、成長、動向、予測、2024~2031年

Genetic Toxicology Testing Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

出版日: | 発行: Persistence Market Research | ページ情報: 英文 289 Pages | 納期: 2~5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=159.16円
遺伝子毒性検査市場:製品タイプ、エンドユーザー、地域別:世界の産業分析、規模、シェア、成長、動向、予測、2024~2031年
出版日: 2024年05月16日
発行: Persistence Market Research
ページ情報: 英文 289 Pages
納期: 2~5営業日
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Researchは、世界の遺伝子毒性検査市場を詳細に分析し、市場力学、成長促進要因、課題、新興動向に関する考察を提供しています。当レポートは、市場情勢をナビゲートするための詳細なデータと統計を提供し、利害関係者の包括的なリソースとして役立ちます。

世界の遺伝子毒性検査市場は、2024~2031年にかけて力強い成長を遂げると予測され、CAGRは13%と予測されます。市場は2024年の評価額17億1,000万米ドルから、2031年末には40億2,000万米ドルに拡大すると推定されます。

主要洞察

  • 推定市場規模(2024年):17億1,000万米ドル
  • 予測市場価格(2031年):40億2,000万米ドル
  • 世界市場成長率(CAGR 2024~2031年):13%

遺伝子毒性検査市場-レポート範囲:

遺伝子毒性検査は、化学物質の潜在的な変異原性と発がん性の評価において重要な役割を果たしています。DNA損傷、染色体異常、遺伝子変異を評価するための様々なin vitroとin vivoアッセイを含みます。医薬品、化学物質、食品産業における安全性評価への注目の高まりが、遺伝子毒性検査の需要を牽引しています。

規制機関は、消費者の安全性を確保するため、製品開発と承認プロセスの一環として遺伝子毒性検査を義務付けています。さらに、ハイスループット・スクリーニングや計算モデリングなどの調査手法の進歩が、遺伝子毒性評価の効率と精度を高めています。

市場促進要因:

遺伝子毒性検査市場の成長は、製品の安全性評価に関する厳しい規制要件や慢性疾患の有病率の上昇など、いくつかの要因によってもたらされます。米国食品医薬品局(FDA)や欧州医薬品庁(EMA)などの規制機関は、潜在的な健康リスクを評価するため、新規化学物質や医薬品の遺伝子毒性検査を義務付けています。

さらに、インシリコ・モデリングや臓器オンチップ技術などの代替検査法の採用が増加しており、動物モデルへの依存を減らしつつ検査プロセスを加速させています。このような代替検査法へのシフトは、倫理的と規制上の考慮事項と合致し、市場の成長を促進します。

市場抑制要因:

遺伝子毒性検査市場は、その前向きな成長軌道にもかかわらず、検査手順の高コストやエンドユーザーの認知度の低さなどの課題に直面しています。遺伝子毒性検査には、専門的な機器、熟練した人材、多額の財政投資が必要であり、中小企業が包括的な安全性評価を実施する妨げとなる可能性があります。

さらに、標準化されたプロトコルがなく、検査所間で検査結果にばらつきがあるため、規制当局の受け入れと比較可能性に課題があります。これらの課題に対処するためには、利害関係者が協力して調和されたガイドラインを策定し、遺伝子毒性検査の信頼性と再現性を確保する必要があります。

市場機会:

遺伝子毒性検査市場は、特に新興経済国やニッチ用途において、技術革新と拡大の大きな機会を提供しています。精密医療や個別化医療の導入が進む中、環境暴露や薬剤誘発毒性に対する個人の感受性を評価する遺伝子毒性検査サービスの需要が高まっています。

さらに、ゲノミクスとバイオインフォマティクスの進歩は、バイオマーカー探索や遺伝子毒性経路のメカニズム解明への新たな道を提供しています。ゲノミクス、トランスクリプトミクス、メタボロミクスなどのオミクス技術を統合することで、遺伝子毒性検査の予測力が強化され、オーダーメイドのリスク評価が可能になります。

本レポートで扱う主要質問

  • 2024~2031年までの遺伝子毒性検査市場の期待値CAGRは?
  • 遺伝子毒性検査市場の成長を促進する主要要因は何か?
  • 遺伝子毒性検査市場で最大の市場シェアを占める地域はどこか?
  • 遺伝子毒性検査の世界市場における主要参入企業は?
  • 遺伝子毒性検査市場の成長を維持するために主要企業はどのような戦略を採用しているか?

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/ 分類
  • 市場の定義/ 範囲/ 制限

第3章 市場背景

  • 市場力学
  • シナリオ予測
  • 機会マップ分析
  • 投資実現可能性マトリックス
  • PESTLEとポーター分析
  • 規制状況
  • 地域親市場展望

第4章 世界の遺伝子毒性検査市場分析

  • 過去の市場規模・金額(100万米ドル)分析、2019~2023年
  • 現在と将来の市場規模・金額(100万米ドル)予測、2024~2031年
    • 前年比成長動向分析
    • 絶対金額機会分析

第5章 タイプ別の世界の遺伝子毒性検査市場分析

  • イントロダクション/主要調査結果
  • 過去の市場規模価値(100万米ドル)の分析、タイプ別、2019~2023年
  • 現在の市場規模価値(100万米ドル)分析と予測、タイプ別、2024~2031年
    • 検査管内で
    • 生体内
  • タイプ別の前年比成長動向分析、2019~2023年
  • タイプ別の絶対金額機会分析、2024~2031年

第6章 製品別の世界の遺伝子毒性検査市場分析

  • イントロダクション/主要調査結果
  • 過去の市場規模価値(100万米ドル)の分析、製品別、2019~2023年
  • 現在の市場規模価値(100万米ドル)分析と予測、製品別、2024~2031年
    • 試薬・消耗品
    • アッセイ
    • サービス
  • 製品別の前年比成長動向分析、2019~2023年
  • 製品別の絶対金額機会分析、2024~2031年

第7章 用途別の世界の遺伝子毒性検査市場分析

  • イントロダクション/主要調査結果
  • 過去の市場規模価値(100万米ドル)の分析、用途別、2019~2023年
  • 現在の市場規模価値(100万米ドル)分析と予測、用途別、2024~2031年
    • 製薬・バイオテクノロジー
    • 食品業界
    • 化粧品業界
    • その他
  • 用途別の前年比成長動向分析、2019~2023年
  • 用途別の絶対金額機会分析、2024~2031年

第8章 地域別の世界の遺伝子毒性検査市場分析

  • イントロダクション
  • 過去の市場規模価値(100万米ドル)の分析、地域別、2019~2023年
  • 現在の市場規模価値(100万米ドル)分析と予測、地域別、2024~2031年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 南アジア
    • 東アジア
    • オセアニア
    • 中東・アフリカ
  • 地域別市場魅力度分析

第9章 北米の遺伝子毒性検査市場分析:国別

第10章 ラテンアメリカの遺伝子毒性検査市場分析:国別

第11章 欧州の遺伝子毒性検査市場分析:国別

第12章 南アジアの遺伝子毒性検査市場分析:国別

第13章 東アジアの遺伝子毒性検査市場分析:国別

第14章 オセアニアの遺伝子毒性検査市場分析:国別

第15章 中東・アフリカの遺伝子毒性検査市場分析:国別

第16章 主要国の遺伝子毒性検査市場分析

  • 米国
  • カナダ
  • ブラジル
  • メキシコ
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • インド
  • マレーシア
  • シンガポール
  • タイ
  • 中国
  • 日本
  • 韓国
  • オーストラリア
  • ニュージーランド
  • GCC諸国
  • 南アフリカ
  • イスラエル

第17章 市場構造分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 主要企業の市場シェア分析

第18章 競合分析

  • 競合の詳細
    • Thermo Fisher Scientific, Inc.
    • Charles River Laboratories International
    • Laboratory Corp of America Holdings
    • Eurofins Scientific
    • Jubilant Life Sciences Limited
    • Syngene International Limited
    • Gentronix Ltd.
    • Inotiv Inc.
    • Creative Bioarray
    • MB Research Laboratories

第19章 使用される仮定と頭字語

第20章 調査手法

目次
Product Code: PMRREP33213

Persistence Market Research presents an in-depth analysis of the global Genetic Toxicology Testing Market, offering insights into market dynamics, growth drivers, challenges, and emerging trends. This report serves as a comprehensive resource for stakeholders, providing detailed data and statistics to navigate the market landscape.

The global genetic toxicology testing market is projected to experience robust growth between 2024 and 2031, with a forecasted CAGR of 13%. The market is estimated to expand from a valuation of USD 1.71 billion in 2024 to USD 4.02 billion by the end of 2031.

Key Insights:

  • Estimated Market Value (2024): USD 1.71 Billion
  • Projected Market Value (2031): USD 4.02 Billion
  • Global Market Growth Rate (CAGR 2024 to 2031): 13%

Genetic Toxicology Testing Market - Report Scope:

Genetic toxicology testing plays a critical role in assessing the potential mutagenic and carcinogenic properties of chemical substances. It involves various in vitro and in vivo assays to evaluate DNA damage, chromosomal aberrations, and gene mutations. The increasing focus on safety assessment in pharmaceuticals, chemicals, and food industries drives the demand for genetic toxicology testing.

Regulatory agencies mandate genetic toxicology testing as part of the product development and approval process to ensure consumer safety. Additionally, advancements in testing methodologies, such as high-throughput screening and computational modeling, enhance the efficiency and accuracy of genetic toxicology assessments.

Market Growth Drivers:

The growth of the genetic toxicology testing market is driven by several factors, including stringent regulatory requirements for product safety assessment and the rising prevalence of chronic diseases. Regulatory agencies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), mandate genetic toxicology testing for new chemical entities and pharmaceuticals to evaluate potential health risks.

Furthermore, the increasing adoption of alternative testing methods, such as in silico modeling and organ-on-a-chip technology, accelerates the testing process while reducing reliance on animal models. This shift towards alternative testing methods aligns with ethical and regulatory considerations and drives market growth.

Market Restraints:

Despite its positive growth trajectory, the genetic toxicology testing market faces challenges, including the high cost of testing procedures and limited awareness among end-users. Genetic toxicology testing requires specialized equipment, skilled personnel, and substantial financial investment, which can deter small and medium-sized enterprises (SMEs) from conducting comprehensive safety assessments.

Additionally, the lack of standardized protocols and variability in test results across laboratories pose challenges for regulatory acceptance and comparability. Addressing these challenges requires collaboration among stakeholders to develop harmonized guidelines and ensure the reliability and reproducibility of genetic toxicology testing.

Market Opportunities:

The genetic toxicology testing market presents significant opportunities for innovation and expansion, particularly in emerging economies and niche applications. With the increasing adoption of precision medicine and personalized healthcare, there is a growing demand for genetic toxicology testing services to assess individual susceptibility to environmental exposures and drug-induced toxicities.

Moreover, advancements in genomics and bioinformatics offer new avenues for biomarker discovery and mechanistic insights into genotoxicity pathways. Integrating omics technologies, such as genomics, transcriptomics, and metabolomics, enhances the predictive power of genetic toxicology testing and enables tailored risk assessments.

Key Questions Addressed in the Report:

  • What is the Expected Value CAGR of the Genetic Toxicology Testing Market from 2024 to 2031?
  • What are the Key Factors Driving the Growth of the Genetic Toxicology Testing Market?
  • Which Region Holds the Largest Market Share in the Genetic Toxicology Testing Market?
  • Who are the Key Players in the Global Genetic Toxicology Testing Market?
  • What Strategies are Adopted by Leading Companies to Sustain Growth in the Genetic Toxicology Testing Market?

Competitive Landscape and Business Strategies:

Prominent companies in the genetic toxicology testing market include Covance Inc., Eurofins Scientific, Charles River Laboratories International, Inc., and Thermo Fisher Scientific Inc. These companies focus on strategic initiatives such as mergers and acquisitions, collaborations, and product innovations to strengthen their market position and expand their service offerings.

Additionally, investments in research and development facilitate the development of novel testing platforms and methodologies to address evolving regulatory requirements and customer needs. Collaborations with academic institutions and regulatory agencies further enhance technical expertise and regulatory compliance.

Key Companies Profiled:

  • Covance Inc.
  • Eurofins Scientific
  • Charles River Laboratories International, Inc.
  • Thermo Fisher Scientific Inc.
  • SGS SA
  • Bureau Veritas S.A.
  • Intertek Group plc
  • BioReliance Corporation
  • Gentronix Limited
  • Cyprotex PLC

Genetic Toxicology Testing Market Segmentation:

By Type

  • In Vitro
  • In Vivo

By Product

  • Reagents & Consumables
  • Assays
  • Services

By Application

  • Pharmaceutical & Biotechnology
  • Food Industry
  • Cosmetics Industry
  • Other

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand-side Trends
  • 1.3. Supply-side Trends
  • 1.4. Technology Roadmap Analysis
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Background

  • 3.1. Market Dynamics
    • 3.1.1. Drivers
    • 3.1.2. Restraints
    • 3.1.3. Opportunity
    • 3.1.4. Trends
  • 3.2. Scenario Forecast
    • 3.2.1. Demand in Optimistic Scenario
    • 3.2.2. Demand in Likely Scenario
    • 3.2.3. Demand in Conservative Scenario
  • 3.3. Opportunity Map Analysis
  • 3.4. Investment Feasibility Matrix
  • 3.5. PESTLE and Porter's Analysis
  • 3.6. Regulatory Landscape
    • 3.6.1. By Key Regions
    • 3.6.2. By Key Countries
  • 3.7. Regional Parent Market Outlook

4. Global Genetic Toxicology Testing Market Analysis 2019-2023 and Forecast, 2024-2031

  • 4.1. Historical Market Size Value (US$ Mn) Analysis, 2019-2023
  • 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2024-2031
    • 4.2.1. Y-o-Y Growth Trend Analysis
    • 4.2.2. Absolute $ Opportunity Analysis

5. Global Genetic Toxicology Testing Market Analysis 2019-2023 and Forecast 2024-2031, By Type

  • 5.1. Introduction / Key Findings
  • 5.2. Historical Market Size Value (US$ Mn) Analysis By Type , 2019-2023
  • 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Type , 2024-2031
    • 5.3.1. In Vitro
    • 5.3.2. In Vivo
  • 5.4. Y-o-Y Growth Trend Analysis By Type , 2019-2023
  • 5.5. Absolute $ Opportunity Analysis By Type , 2024-2031

6. Global Genetic Toxicology Testing Market Analysis 2019-2023 and Forecast 2024-2031, By Product

  • 6.1. Introduction / Key Findings
  • 6.2. Historical Market Size Value (US$ Mn) Analysis By Product, 2019-2023
  • 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product, 2024-2031
    • 6.3.1. Reagents & Consumables
    • 6.3.2. Assays
    • 6.3.3. Services
  • 6.4. Y-o-Y Growth Trend Analysis By Product, 2019-2023
  • 6.5. Absolute $ Opportunity Analysis By Product, 2024-2031

7. Global Genetic Toxicology Testing Market Analysis 2019-2023 and Forecast 2024-2031, By Application

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size Value (US$ Mn) Analysis By Application , 2019-2023
  • 7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application , 2024-2031
    • 7.3.1. Pharmaceutical & Biotechnology
    • 7.3.2. Food Industry
    • 7.3.3. Cosmetics Industry
    • 7.3.4. Other
  • 7.4. Y-o-Y Growth Trend Analysis By Application , 2019-2023
  • 7.5. Absolute $ Opportunity Analysis By Application , 2024-2031

8. Global Genetic Toxicology Testing Market Analysis 2019-2023 and Forecast 2024-2031, By Region

  • 8.1. Introduction
  • 8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2019-2023
  • 8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2024-2031
    • 8.3.1. North America
    • 8.3.2. Latin America
    • 8.3.3. Europe
    • 8.3.4. South Asia
    • 8.3.5. East Asia
    • 8.3.6. Oceania
    • 8.3.7. MEA
  • 8.4. Market Attractiveness Analysis By Region

9. North America Genetic Toxicology Testing Market Analysis 2019-2023 and Forecast 2024-2031, By Country

  • 9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 9.2.1. By Country
      • 9.2.1.1. U.S.
      • 9.2.1.2. Canada
    • 9.2.2. By Type
    • 9.2.3. By Product
    • 9.2.4. By Application
  • 9.3. Market Attractiveness Analysis
    • 9.3.1. By Country
    • 9.3.2. By Type
    • 9.3.3. By Product
    • 9.3.4. By Application
  • 9.4. Key Takeaways

10. Latin America Genetic Toxicology Testing Market Analysis 2019-2023 and Forecast 2024-2031, By Country

  • 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 10.2.1. By Country
      • 10.2.1.1. Brazil
      • 10.2.1.2. Mexico
      • 10.2.1.3. Rest of Latin America
    • 10.2.2. By Type
    • 10.2.3. By Product
    • 10.2.4. By Application
  • 10.3. Market Attractiveness Analysis
    • 10.3.1. By Country
    • 10.3.2. By Type
    • 10.3.3. By Product
    • 10.3.4. By Application
  • 10.4. Key Takeaways

11. Europe Genetic Toxicology Testing Market Analysis 2019-2023 and Forecast 2024-2031, By Country

  • 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 11.2.1. By Country
      • 11.2.1.1. Germany
      • 11.2.1.2. U.K.
      • 11.2.1.3. France
      • 11.2.1.4. Spain
      • 11.2.1.5. Italy
      • 11.2.1.6. Rest of Europe
    • 11.2.2. By Type
    • 11.2.3. By Product
    • 11.2.4. By Application
  • 11.3. Market Attractiveness Analysis
    • 11.3.1. By Country
    • 11.3.2. By Type
    • 11.3.3. By Product
    • 11.3.4. By Application
  • 11.4. Key Takeaways

12. South Asia Genetic Toxicology Testing Market Analysis 2019-2023 and Forecast 2024-2031, By Country

  • 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 12.2.1. By Country
      • 12.2.1.1. India
      • 12.2.1.2. Malaysia
      • 12.2.1.3. Singapore
      • 12.2.1.4. Thailand
      • 12.2.1.5. Rest of South Asia
    • 12.2.2. By Type
    • 12.2.3. By Product
    • 12.2.4. By Application
  • 12.3. Market Attractiveness Analysis
    • 12.3.1. By Country
    • 12.3.2. By Type
    • 12.3.3. By Product
    • 12.3.4. By Application
  • 12.4. Key Takeaways

13. East Asia Genetic Toxicology Testing Market Analysis 2019-2023 and Forecast 2024-2031, By Country

  • 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 13.2.1. By Country
      • 13.2.1.1. China
      • 13.2.1.2. Japan
      • 13.2.1.3. South Korea
    • 13.2.2. By Type
    • 13.2.3. By Product
    • 13.2.4. By Application
  • 13.3. Market Attractiveness Analysis
    • 13.3.1. By Country
    • 13.3.2. By Type
    • 13.3.3. By Product
    • 13.3.4. By Application
  • 13.4. Key Takeaways

14. Oceania Genetic Toxicology Testing Market Analysis 2019-2023 and Forecast 2024-2031, By Country

  • 14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 14.2.1. By Country
      • 14.2.1.1. Australia
      • 14.2.1.2. New Zealand
    • 14.2.2. By Type
    • 14.2.3. By Product
    • 14.2.4. By Application
  • 14.3. Market Attractiveness Analysis
    • 14.3.1. By Country
    • 14.3.2. By Type
    • 14.3.3. By Product
    • 14.3.4. By Application
  • 14.4. Key Takeaways

15. MEA Genetic Toxicology Testing Market Analysis 2019-2023 and Forecast 2024-2031, By Country

  • 15.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 15.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 15.2.1. By Country
      • 15.2.1.1. GCC Countries
      • 15.2.1.2. South Africa
      • 15.2.1.3. Israel
      • 15.2.1.4. Rest of MEA
    • 15.2.2. By Type
    • 15.2.3. By Product
    • 15.2.4. By Application
  • 15.3. Market Attractiveness Analysis
    • 15.3.1. By Country
    • 15.3.2. By Type
    • 15.3.3. By Product
    • 15.3.4. By Application
  • 15.4. Key Takeaways

16. Key Countries Genetic Toxicology Testing Market Analysis

  • 16.1. U.S.
    • 16.1.1. Pricing Analysis
    • 16.1.2. Market Share Analysis, 2024
      • 16.1.2.1. By Type
      • 16.1.2.2. By Product
      • 16.1.2.3. By Application
  • 16.2. Canada
    • 16.2.1. Pricing Analysis
    • 16.2.2. Market Share Analysis, 2024
      • 16.2.2.1. By Type
      • 16.2.2.2. By Product
      • 16.2.2.3. By Application
  • 16.3. Brazil
    • 16.3.1. Pricing Analysis
    • 16.3.2. Market Share Analysis, 2024
      • 16.3.2.1. By Type
      • 16.3.2.2. By Product
      • 16.3.2.3. By Application
  • 16.4. Mexico
    • 16.4.1. Pricing Analysis
    • 16.4.2. Market Share Analysis, 2024
      • 16.4.2.1. By Type
      • 16.4.2.2. By Product
      • 16.4.2.3. By Application
  • 16.5. Germany
    • 16.5.1. Pricing Analysis
    • 16.5.2. Market Share Analysis, 2024
      • 16.5.2.1. By Type
      • 16.5.2.2. By Product
      • 16.5.2.3. By Application
  • 16.6. U.K.
    • 16.6.1. Pricing Analysis
    • 16.6.2. Market Share Analysis, 2024
      • 16.6.2.1. By Type
      • 16.6.2.2. By Product
      • 16.6.2.3. By Application
  • 16.7. France
    • 16.7.1. Pricing Analysis
    • 16.7.2. Market Share Analysis, 2024
      • 16.7.2.1. By Type
      • 16.7.2.2. By Product
      • 16.7.2.3. By Application
  • 16.8. Spain
    • 16.8.1. Pricing Analysis
    • 16.8.2. Market Share Analysis, 2024
      • 16.8.2.1. By Type
      • 16.8.2.2. By Product
      • 16.8.2.3. By Application
  • 16.9. Italy
    • 16.9.1. Pricing Analysis
    • 16.9.2. Market Share Analysis, 2024
      • 16.9.2.1. By Type
      • 16.9.2.2. By Product
      • 16.9.2.3. By Application
  • 16.10. India
    • 16.10.1. Pricing Analysis
    • 16.10.2. Market Share Analysis, 2024
      • 16.10.2.1. By Type
      • 16.10.2.2. By Product
      • 16.10.2.3. By Application
  • 16.11. Malaysia
    • 16.11.1. Pricing Analysis
    • 16.11.2. Market Share Analysis, 2024
      • 16.11.2.1. By Type
      • 16.11.2.2. By Product
      • 16.11.2.3. By Application
  • 16.12. Singapore
    • 16.12.1. Pricing Analysis
    • 16.12.2. Market Share Analysis, 2024
      • 16.12.2.1. By Type
      • 16.12.2.2. By Product
      • 16.12.2.3. By Application
  • 16.13. Thailand
    • 16.13.1. Pricing Analysis
    • 16.13.2. Market Share Analysis, 2024
      • 16.13.2.1. By Type
      • 16.13.2.2. By Product
      • 16.13.2.3. By Application
  • 16.14. China
    • 16.14.1. Pricing Analysis
    • 16.14.2. Market Share Analysis, 2024
      • 16.14.2.1. By Type
      • 16.14.2.2. By Product
      • 16.14.2.3. By Application
  • 16.15. Japan
    • 16.15.1. Pricing Analysis
    • 16.15.2. Market Share Analysis, 2024
      • 16.15.2.1. By Type
      • 16.15.2.2. By Product
      • 16.15.2.3. By Application
  • 16.16. South Korea
    • 16.16.1. Pricing Analysis
    • 16.16.2. Market Share Analysis, 2024
      • 16.16.2.1. By Type
      • 16.16.2.2. By Product
      • 16.16.2.3. By Application
  • 16.17. Australia
    • 16.17.1. Pricing Analysis
    • 16.17.2. Market Share Analysis, 2024
      • 16.17.2.1. By Type
      • 16.17.2.2. By Product
      • 16.17.2.3. By Application
  • 16.18. New Zealand
    • 16.18.1. Pricing Analysis
    • 16.18.2. Market Share Analysis, 2024
      • 16.18.2.1. By Type
      • 16.18.2.2. By Product
      • 16.18.2.3. By Application
  • 16.19. GCC Countries
    • 16.19.1. Pricing Analysis
    • 16.19.2. Market Share Analysis, 2024
      • 16.19.2.1. By Type
      • 16.19.2.2. By Product
      • 16.19.2.3. By Application
  • 16.20. South Africa
    • 16.20.1. Pricing Analysis
    • 16.20.2. Market Share Analysis, 2024
      • 16.20.2.1. By Type
      • 16.20.2.2. By Product
      • 16.20.2.3. By Application
  • 16.21. Israel
    • 16.21.1. Pricing Analysis
    • 16.21.2. Market Share Analysis, 2024
      • 16.21.2.1. By Type
      • 16.21.2.2. By Product
      • 16.21.2.3. By Application

17. Market Structure Analysis

  • 17.1. Competition Dashboard
  • 17.2. Competition Benchmarking
  • 17.3. Market Share Analysis of Top Players
    • 17.3.1. By Regional
    • 17.3.2. By Type
    • 17.3.3. By Product
    • 17.3.4. By Application

18. Competition Analysis

  • 18.1. Competition Deep Dive
    • 18.1.1. Thermo Fisher Scientific, Inc.
      • 18.1.1.1. Overview
      • 18.1.1.2. Product Portfolio
      • 18.1.1.3. Profitability by Market Segments
      • 18.1.1.4. Sales Footprint
      • 18.1.1.5. Strategy Overview
        • 18.1.1.5.1. Marketing Strategy
    • 18.1.2. Charles River Laboratories International
      • 18.1.2.1. Overview
      • 18.1.2.2. Product Portfolio
      • 18.1.2.3. Profitability by Market Segments
      • 18.1.2.4. Sales Footprint
      • 18.1.2.5. Strategy Overview
        • 18.1.2.5.1. Marketing Strategy
    • 18.1.3. Laboratory Corp of America Holdings
      • 18.1.3.1. Overview
      • 18.1.3.2. Product Portfolio
      • 18.1.3.3. Profitability by Market Segments
      • 18.1.3.4. Sales Footprint
      • 18.1.3.5. Strategy Overview
        • 18.1.3.5.1. Marketing Strategy
    • 18.1.4. Eurofins Scientific
      • 18.1.4.1. Overview
      • 18.1.4.2. Product Portfolio
      • 18.1.4.3. Profitability by Market Segments
      • 18.1.4.4. Sales Footprint
      • 18.1.4.5. Strategy Overview
        • 18.1.4.5.1. Marketing Strategy
    • 18.1.5. Jubilant Life Sciences Limited
      • 18.1.5.1. Overview
      • 18.1.5.2. Product Portfolio
      • 18.1.5.3. Profitability by Market Segments
      • 18.1.5.4. Sales Footprint
      • 18.1.5.5. Strategy Overview
        • 18.1.5.5.1. Marketing Strategy
    • 18.1.6. Syngene International Limited
      • 18.1.6.1. Overview
      • 18.1.6.2. Product Portfolio
      • 18.1.6.3. Profitability by Market Segments
      • 18.1.6.4. Sales Footprint
      • 18.1.6.5. Strategy Overview
        • 18.1.6.5.1. Marketing Strategy
    • 18.1.7. Gentronix Ltd.
      • 18.1.7.1. Overview
      • 18.1.7.2. Product Portfolio
      • 18.1.7.3. Profitability by Market Segments
      • 18.1.7.4. Sales Footprint
      • 18.1.7.5. Strategy Overview
        • 18.1.7.5.1. Marketing Strategy
    • 18.1.8. Inotiv Inc.
      • 18.1.8.1. Overview
      • 18.1.8.2. Product Portfolio
      • 18.1.8.3. Profitability by Market Segments
      • 18.1.8.4. Sales Footprint
      • 18.1.8.5. Strategy Overview
        • 18.1.8.5.1. Marketing Strategy
    • 18.1.9. Creative Bioarray
      • 18.1.9.1. Overview
      • 18.1.9.2. Product Portfolio
      • 18.1.9.3. Profitability by Market Segments
      • 18.1.9.4. Sales Footprint
      • 18.1.9.5. Strategy Overview
        • 18.1.9.5.1. Marketing Strategy
    • 18.1.10. MB Research Laboratories
      • 18.1.10.1. Overview
      • 18.1.10.2. Product Portfolio
      • 18.1.10.3. Profitability by Market Segments
      • 18.1.10.4. Sales Footprint
      • 18.1.10.5. Strategy Overview
        • 18.1.10.5.1. Marketing Strategy

19. Assumptions & Acronyms Used

20. Research Methodology